Global Glycyrrhiza Glabra Root Extract Market Strategic Research Report
By Type: Pharmaceutical Grade, Food Grade, Feed Grade, Others
By Application: Cosmetic, Pharmaceutical, Food Industry, Tobacco Industry, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Xinjiang Long Hui Yuan Pharmaceutical Co., Ltd. (CN), Qinghai Beili Licorice Science and Technology Co., Ltd. (CN), Gansu Fanzhi Pharmaceutical Co., Ltd. (CN), Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co., Ltd. (CN), Agrolic Impex (UZ), Sepidan Osareh (IR), F&C Licorice (IS), Norevo GmbH (DE), Ransom Naturals (UK), Zagros Licorice (IR), Mafco Worldwide (US), Maruzen Pharmaceuticals (JP), Aushadhi Herbal (IN), VPL Chemicals (IN)
Overview
Scope of the Report
The global Glycyrrhiza Glabra Root Extract market size is predicted to grow from US$ 251 million in 2025 to US$ 402 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
In 2025, the global sales volume of Glycyrrhiza glabra root extract reached 11,000 metric tons, with an average price of $23,053 per ton.
Glycyrrhiza glabra, a flowering plant of the bean family Fabaceae, from the root of which a sweet, aromatic flavouring can be extracted. The liquorice plant is a herbaceous perennial legume native to the Western Asia and southern Europe.It is not botanically related to anise, star anise, or fennel, which are sources of similar flavouring compounds. Liquorice is used as a flavouring in candies and tobacco, particularly in some European and West Asian countries. Glycyrrhiza glabra root extracts have been used in herbalism and traditional medicine.
The raw material for Glycyrrhiza glabra root extract consists of the dried roots and rhizomes of Glycyrrhiza glabra. This perennial herbaceous legume has extremely strict requirements regarding its growing environment and is primarily distributed across the Mediterranean coast, West Asia, Central Asia, and regions in China such as Xinjiang, Gansu, and Inner Mongolia.
The cost structure of Glycyrrhiza glabra root extract is characterized by a very high proportion of raw material costs and significant value-added from processing technology, with substantial price variations depending on the product grade. For standard food-grade crude extracts, raw material costs account for approximately 35%–45% of the total cost, with the market wholesale price of dried *Glycyrrhiza glabra* roots ranging from roughly $9 to $17 per kilogram. In contrast, the total cost of pharmaceutical-grade standardized extracts is about two to three times that of food-grade products, due to additional expenses associated with purification, testing, and GMP certification. The most extreme cost structure is found in cosmetic-grade high-purity glabridin; raw material costs exceed 50%–60% of the total, reflecting the complexity of the extraction and purification processes.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glycyrrhiza Glabra Root Extract market?
What factors are driving Glycyrrhiza Glabra Root Extract market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glycyrrhiza Glabra Root Extract market opportunities vary by end market size?
How does Glycyrrhiza Glabra Root Extract break out by Type, by Application?
This report presents a comprehensive overview of the global Glycyrrhiza Glabra Root Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Pharmaceutical Grade
- Food Grade
- Feed Grade
- Others
Segment by Product Form
- Powder
- Fluid Extract
- Solid Extract Block
- Other
Segment by Glycyrrhizic Acid Content
- >20%
- 10-20%
- <10%
Segment by Application
- Cosmetic
- Pharmaceutical
- Food Industry
- Tobacco Industry
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Glycyrrhiza Glabra Root Extract market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Cosmetic, Pharmaceutical, Food Industry evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Glycyrrhiza Glabra Root Extract Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Pharmaceutical Grade
- 3.1.3 Food Grade
- 3.1.4 Feed Grade
- 3.1.5 Others
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Cosmetic
- 4.1.3 Pharmaceutical
- 4.1.4 Food Industry
- 4.1.5 Tobacco Industry
- 4.1.6 Others
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Xinjiang Long Hui Yuan Pharmaceutical Co., Ltd. (CN)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Qinghai Beili Licorice Science and Technology Co., Ltd. (CN)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Gansu Fanzhi Pharmaceutical Co., Ltd. (CN)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Zhangjiagang Free Trade Zone Hongyufeng Biotechnology Co., Ltd. (CN)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Agrolic Impex (UZ)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Sepidan Osareh (IR)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 F&C Licorice (IS)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Norevo GmbH (DE)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Ransom Naturals (UK)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Zagros Licorice (IR)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Mafco Worldwide (US)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Maruzen Pharmaceuticals (JP)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Aushadhi Herbal (IN)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 VPL Chemicals (IN)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Glycyrrhiza Glabra Root Extract market size?
What growth rate is expected for the Glycyrrhiza Glabra Root Extract market through 2032?
How is Glycyrrhiza Glabra Root Extract defined?
How is the Glycyrrhiza Glabra Root Extract market segmented by type?
What are the key applications of Glycyrrhiza Glabra Root Extract?
Which companies are profiled in the Glycyrrhiza Glabra Root Extract market report?
What geographies does the Glycyrrhiza Glabra Root Extract market analysis include?
What are the key demand drivers for Glycyrrhiza Glabra Root Extract?
Who should buy the Glycyrrhiza Glabra Root Extract market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Glycyrrhiza Glabra Root Extract Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials